Literature DB >> 1404133

The economic impacts of juvenile rheumatoid arthritis.

S H Allaire1, B S DeNardo, I S Szer, R F Meenan, J G Schaller.   

Abstract

Our study documents the direct costs, family costs and community (extra school) costs. One hundred and twenty families with children who had juvenile rheumatoid arthritis (JRA) diagnosed by established criteria and who lived in New England were asked to participate. All data except inpatient charged were collected via questionnaire. The questionnaire return rate was 59% (N = 70). The mean annualized direct cost/child was 7,905 (inpatient, $1,717; outpatient, $5,700; and nonmedical, $488). Family costs averaged $1,524/year (out of pocket medical and nonmedical, $1,196; lost salary, $328), which represented 5% of mean family income. The mean extra school cost was $1,449/9 months. The economic impacts of JRA appear to be substantial.

Entities:  

Mesh:

Year:  1992        PMID: 1404133

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.

Authors:  Wendy Gidman; Rachel Meacock; Deborah Symmons
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

Review 2.  Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization.

Authors:  Nicolino Ruperto; Alberto Martini
Journal:  World J Pediatr       Date:  2008-08       Impact factor: 2.764

3.  Cost of biologics in the treatment of juvenile idiopathic arthritis: a factor not to be overlooked.

Authors:  Femke H M Prince; Lisette W A van Suijlekom-Smit
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

Review 4.  The costs of rheumatoid arthritis.

Authors:  S H Allaire; M J Prashker; R F Meenan
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

5.  Outcome measures in pediatric rheumatology.

Authors:  Sujata Sawhney; Manjari Agarwal
Journal:  Indian J Pediatr       Date:  2010-10-12       Impact factor: 1.967

6.  Burden of childhood-onset arthritis.

Authors:  Lakshmi N Moorthy; Margaret Ge Peterson; Afton L Hassett; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

7.  Burden and cost of illness in patients with juvenile idiopathic arthritis.

Authors:  K Minden; M Niewerth; J Listing; T Biedermann; M Schöntube; A Zink
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

8.  The economic impact of musculoskeletal disorders.

Authors:  P Lee
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

9.  Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever.

Authors:  Ilker Kemal Yucel; Emire Seyahi; Ozgur Kasapcopur; Nil Arisoy
Journal:  Rheumatol Int       Date:  2011-04-03       Impact factor: 2.631

10.  Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis.

Authors:  J Thornton; M Lunt; D M Ashcroft; E Baildam; H Foster; J Davidson; J Gardner-Medwin; M W Beresford; D Symmons; W Thomson; R A Elliott
Journal:  Rheumatology (Oxford)       Date:  2008-04-16       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.